Quanterix (QTRX) Change in Account Payables (2017 - 2026)
Quanterix (QTRX) reported Change in Account Payables of -$4.8 million for Q1 2026, down 1314.54% on a YoY basis from $399000.0 in Q1 2025, and down 261.05% quarter-over-quarter from $3.0 million in Q4 2025.
Quanterix (QTRX) Change in Account Payables (2017 - 2026) Analysis & Trends
Quanterix has reported Change in Account Payables for 10 years, with the latest figure at -$4.8 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 1314.54% year-over-year to -$4.8 million; the trailing twelve-month figure through Mar 2026 stood at -$5.8 million (down 364.94% YoY), and the FY2025 full-year result was -$528000.0, down 173.03% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$4.8 million, down from $3.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $3.1 million in Q2 2024, with the low at -$6.3 million in Q3 2025.
- Historically, Change in Account Payables has averaged -$514647.1 across 5 years, with a median of $241000.0 in 2023.
- Annual changes were most pronounced in 2025 — Change in Account Payables jumped 2128.89% — and 2026, when it plunged 1314.54%.
- Quanterix's Change in Account Payables stood at $1.7 million in 2022, then tumbled by 86.01% to $241000.0 in 2023, then sank by 43.98% to $135000.0 in 2024, then jumped by 2128.89% to $3.0 million in 2025, then sank by 261.05% to -$4.8 million in 2026.
- The last three Change in Account Payables figures came in at -$4.8 million (Q1 2026), $3.0 million (Q4 2025), and -$6.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 221.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Quanterix | 146.10 Mn | 46.84 Mn | 15.57 Mn | -4.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.85 Mn |
| Mar 31, 2026 | -4.85 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Sep 30, 2025 | -6.33 Mn |
| Sep 30, 2025 | -6.33 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 399,000.00 |
| Mar 31, 2025 | 399,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | -1.47 Mn |
| Sep 30, 2024 | -1.47 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | 241,000.00 |
| Dec 31, 2023 | 241,000.00 |